mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.004 |
mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.004 |
mRNA |
AZD8055 |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.005 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.006 |
mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.006 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.006 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.007 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.007 |
mRNA |
NVP-BSK805 |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.008 |
mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.009 |